{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T07:21:29Z","timestamp":1789888889685,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.atherosclerosis.2011.09.050","type":"journal-article","created":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T18:50:03Z","timestamp":1318013403000},"page":"329-336","source":"Crossref","is-referenced-by-count":67,"title":["Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells"],"prefix":"10.1016","volume":"220","author":[{"given":"Thore","family":"Dietrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hucko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Schneemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Menrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Willuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstin","family":"Atrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietger","family":"Stibenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckart","family":"Fleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristof","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans D.","family":"Menssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: cominancee of pro-inflammatory (Th1) an macrophage-stimulating cytokines","volume":"145","author":"Frostegard","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/01.CIR.104.2.197","article-title":"In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice","volume":"104","author":"Laurat","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0015","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1073\/pnas.0409015102","article-title":"T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses","volume":"102","author":"Buono","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0020","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.ATV.0000259365.31469.89","article-title":"Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis","volume":"27","author":"Mor","year":"2007","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2011.04.029","article-title":"Differential effects of regulatory T cells on the initiation and regression of atherosclerosis","volume":"218","author":"Foks","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0030","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.109.863431","article-title":"Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice","volume":"120","author":"Sasaki","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/000331970405500308","article-title":"Atherogeneic effect of interleukin-2 and antiatherogeneic effect of interleukin-2 antibody in apo-E-deficient mice","volume":"55","author":"Upadhya","year":"2004","journal-title":"Angiology"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0040","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/eji.200737791","article-title":"IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells","volume":"38","author":"Brandenburg","year":"2008","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1084\/jem.20041982","article-title":"Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization","volume":"201","author":"Setoguchi","year":"2005","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0050","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood-2006-02-004747","article-title":"IL-2 regulates FOXP3 expression in human CD4+ CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo","volume":"108","author":"Zorn","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0055","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1073\/pnas.0903158107","article-title":"Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus","volume":"107","author":"Humrich","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"Nature Medicine"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0065","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/CIRCULATIONAHA.110.973222","article-title":"Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice","volume":"123","author":"Hermansson","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0070","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/01.RES.0000150373.15149.ff","article-title":"Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin","volume":"95","author":"Matter","year":"2004","journal-title":"Circulation Research"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0075","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00395-007-0652-5","article-title":"ED-B fibronectin (ED-B) can be targeted using a novel single chain antibody conjugate and is associated with macrophage accumulation in atherosclerotic lesions","volume":"102","author":"Dietrich","year":"2007","journal-title":"Basic Research in Cardiology"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.atherosclerosis.2010.11.027","article-title":"Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies","volume":"214","author":"Fiechter","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0085","doi-asserted-by":"crossref","first-page":"21769","DOI":"10.1074\/jbc.273.34.21769","article-title":"Design and use of a phage display library","volume":"273","author":"Pini","year":"1998","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0090","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.V99.5.1659","article-title":"Enhancement of the antitumor proprties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix","volume":"99","author":"Carnemolla","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0095","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood-2008-06-160416","article-title":"Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients","volume":"113","author":"Sauer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10554-009-9487-5","article-title":"High resolution magnetic resonance imaging in atherosclerotic mice treated with ezetimibe","volume":"25","author":"Dietrich","year":"2009","journal-title":"The International Journal of Cardiovascular Imaging"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2310\/7290.2008.0009","article-title":"Monitoring therapeutical intervention with ezetimibe using targeted near-infrared fluorescence imaging in experimental atherosclerosis","volume":"7","author":"Graf","year":"2008","journal-title":"Molecular Imaging"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0110","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1016\/j.ejca.2010.07.033","article-title":"The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma","volume":"46","author":"Johannsen","year":"2010","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0115","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.4049\/jimmunol.172.12.7661","article-title":"NK cells and polymorphnuclear neutrophils are both critical for IL-2 induced pulmonary vascular leak syndrome","volume":"172","author":"Assier","year":"2004","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijcard.2009.07.024","article-title":"FOXP3(+) regulatory T cells in vulnerable atherosclerotic plaques","volume":"145","author":"de Boer","year":"2010","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0125","doi-asserted-by":"crossref","first-page":"e4643","DOI":"10.1371\/journal.pone.0004643","article-title":"Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice","volume":"4","author":"Gogishvili","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cyto.2006.01.009","article-title":"Influence of interleukine-2 and interferon-gamma in murine schistosomiasis","volume":"32","author":"El Ridi","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0135","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1161\/01.ATV.0000139313.69015.1c","article-title":"Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia","volume":"24","author":"Trogan","year":"2004","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0140","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1161\/hc2501.092494","article-title":"High-dose recombinant apolipoprotein A-I (Milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice: potential implications for acute plaque stabilization","volume":"103","author":"Shah","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0145","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1073\/pnas.1016086108","article-title":"HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells","volume":"108","author":"Feig","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.atherosclerosis.2011.09.050_bib0150","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.CIR.0000089083.61317.A1","article-title":"Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice","volume":"108","author":"Mallat","year":"2003","journal-title":"Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011009567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011009567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T05:12:01Z","timestamp":1560748321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915011009567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0021915011009567"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.09.050","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}